Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Drug-Drug Interactions in Prostate Cancer Treatment.

Hebenstreit D, Pichler R, Heidegger I.

Clin Genitourin Cancer. 2019 May 27. pii: S1558-7673(19)30154-5. doi: 10.1016/j.clgc.2019.05.016. [Epub ahead of print] Review.

PMID:
31677899
2.

Potential drug-drug interactions and polypharmacy in institutionalized elderly patients in a public hospital in Brazil.

Castilho ECD, Reis AMM, Borges TL, Siqueira LDC, Miasso AI.

J Psychiatr Ment Health Nurs. 2018 Feb;25(1):3-13. doi: 10.1111/jpm.12431. Epub 2017 Oct 20.

PMID:
28892271
3.

Polypharmacy, aging and potential drug-drug interactions in outpatients in Taiwan: a retrospective computerized screening study.

Lin CF, Wang CY, Bai CH.

Drugs Aging. 2011 Mar 1;28(3):219-25. doi: 10.2165/11586870-000000000-00000.

PMID:
21250763
4.

Statin drug interactions and related adverse reactions: an update.

Bellosta S, Corsini A.

Expert Opin Drug Saf. 2018 Jan;17(1):25-37. doi: 10.1080/14740338.2018.1394455. Epub 2017 Oct 30. Review.

PMID:
29058944
5.

Drug-drug interaction potential in men treated with enzalutamide: Mind the gap.

Benoist GE, van Oort IM, Smeenk S, Javad A, Somford DM, Burger DM, Mehra N, van Erp NP.

Br J Clin Pharmacol. 2018 Jan;84(1):122-129. doi: 10.1111/bcp.13425. Epub 2017 Oct 18.

6.

Polypharmacy in patients with advanced cancer and pain: a European cross-sectional study of 2282 patients.

Kotlinska-Lemieszek A, Paulsen O, Kaasa S, Klepstad P.

J Pain Symptom Manage. 2014 Dec;48(6):1145-59. doi: 10.1016/j.jpainsymman.2014.03.008. Epub 2014 Apr 26.

7.

Potentially inappropriate prescribing and drug-drug interactions among elderly Chinese nursing home residents in Macao.

Lao CK, Ho SC, Chan KK, Tou CF, Tong HH, Chan A.

Int J Clin Pharm. 2013 Oct;35(5):805-12. doi: 10.1007/s11096-013-9811-y. Epub 2013 Jun 28.

PMID:
23812679
9.

High prevalence of potential drug-drug interactions in patients with castration-resistant prostate cancer treated with abiraterone acetate.

Jamani R, Lee EK, Berry SR, Saluja R, DeAngelis C, Giotis A, Emmenegger U.

Eur J Clin Pharmacol. 2016 Nov;72(11):1391-1399. Epub 2016 Aug 25.

PMID:
27561266
10.

Drug-drug interactions in a geriatric outpatient cohort: prevalence and relevance.

Tulner LR, Frankfort SV, Gijsen GJ, van Campen JP, Koks CH, Beijnen JH.

Drugs Aging. 2008;25(4):343-55.

PMID:
18361544
11.

Risk of potential drug-drug interactions among Brazilian elderly: a population-based, cross-sectional study.

Secoli SR, Figueras A, Lebrão ML, de Lima FD, Santos JL.

Drugs Aging. 2010 Sep 1;27(9):759-70. doi: 10.2165/11538460-000000000-00000.

PMID:
20809665
12.

Prevalence and risk of potential cytochrome P450-mediated drug-drug interactions in older hospitalized patients with polypharmacy.

Doan J, Zakrzewski-Jakubiak H, Roy J, Turgeon J, Tannenbaum C.

Ann Pharmacother. 2013 Mar;47(3):324-32. doi: 10.1345/aph.1R621. Epub 2013 Mar 12.

PMID:
23482734
13.

Mechanisms and the clinical relevance of complex drug-drug interactions.

Roberts AG, Gibbs ME.

Clin Pharmacol. 2018 Sep 27;10:123-134. doi: 10.2147/CPAA.S146115. eCollection 2018. Review.

14.

The impact of polypharmacy and drug interactions among the elderly population in Western Sicily, Italy.

Scondotto G, Pojero F, Pollina Addario S, Ferrante M, Pastorello M, Visconti M, Scondotto S, Casuccio A.

Aging Clin Exp Res. 2018 Jan;30(1):81-87. doi: 10.1007/s40520-017-0755-2. Epub 2017 Apr 12.

PMID:
28405956
15.

Quantifying the impact of drug-drug interactions associated with opioids.

Pergolizzi JV.

Am J Manag Care. 2011 Sep;17 Suppl 11:S288-92.

16.

Clinically relevant drug-drug interactions among elderly people with dementia.

Sönnerstam E, Sjölander M, Lövheim H, Gustafsson M.

Eur J Clin Pharmacol. 2018 Oct;74(10):1351-1360. doi: 10.1007/s00228-018-2514-5. Epub 2018 Jul 2.

17.

Drug-drug interactions in a cohort of hospitalized elderly patients.

Pasina L, Djade CD, Nobili A, Tettamanti M, Franchi C, Salerno F, Corrao S, Marengoni A, Iorio A, Marcucci M, Mannucci P.

Pharmacoepidemiol Drug Saf. 2013 Oct;22(10):1054-60. doi: 10.1002/pds.3510. Epub 2013 Aug 30.

PMID:
24038765
18.

Potential drug-drug interactions among prescriptionsfor elderly patients in primary health care.

Gören Z, J Demirkapu M, Akpinar Acet G, Çali S, Gülçebi Idriz Oğlu M.

Turk J Med Sci. 2017 Feb 27;47(1):47-54. doi: 10.3906/sag-1509-89.

PMID:
28263519
19.

Trends in polypharmacy and potential drug-drug interactions across educational groups in elderly patients in Sweden for the period 1992 - 2002.

Haider SI, Johnell K, Thorslund M, Fastbom J.

Int J Clin Pharmacol Ther. 2007 Dec;45(12):643-53.

PMID:
18184532
20.

Epidemiology and characteristics of adverse drug reactions caused by drug-drug interactions.

Magro L, Moretti U, Leone R.

Expert Opin Drug Saf. 2012 Jan;11(1):83-94. doi: 10.1517/14740338.2012.631910. Epub 2011 Oct 25. Review.

PMID:
22022824

Supplemental Content

Support Center